Marinol®, a registered trademark of Unimed Pharmaceuticals, Inc. is the commercial name for a product containing dronabinol, which is synthetic Δ9-tetrahydrocannabinol. Δ9-THC is a naturally occurring component of marijuana. Marinol® is primarily prescribed as an anti-emetic and appetite stimulant for AIDS and chemotherapy patients.

an appetite stimulant composed of TETRAHYDROCANNABINOL (THC), the major psychoactive ingredient in marijuana (see CANNABIS).

Pharmaceutical extract of marijuana, allowed (by U.S. gov't) for those who have prescription for marijuana.